(Bloomberg) -- Kenya will receive its initial batch of Covid-19 vaccines in the first week of March, according to President Uhuru Kenyatta's office.
At least 600,000 doses will come from AstraZeneca Plc under the Covax initiative that's designed to ensure equitable distribution of vaccines, Ronald Inyangala, director for products' registration at Kenya's Pharmacy and Poisons Board, said on Friday. Sinovac Biotech Ltd. and Sputnik V inoculations are still under consideration, Inyangala said.
Health-care workers and frontline personnel, including security officers, teachers, vulnerable people and those in the hospitality sector, will be the first priority for inoculation, the presidency said in a statement following a cabinet meeting on Thursday.
The East African nation expects to vaccinate 16 million of its approximately 53 million people by June next year, Health Secretary Mutahi Kagwe said earlier this month.
Kenya Approves AstraZeneca's Coronavirus Vaccine, Nation Says
©2021 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
